The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country
Open Access
- 29 May 2012
- journal article
- Published by Springer Science and Business Media LLC in Diabetology & Metabolic Syndrome
- Vol. 4 (1), 21-8
- https://doi.org/10.1186/1758-5996-4-21
Abstract
Prevalence of diabetes mellitus (DM) has reached epidemic proportions in Sri Lanka. Presently there are studies on the community prevalence of distal peripheral neuropathy (DPN) in Sri Lanka. We describe prevalence, patterns and predictors of DPN in patients with DM in Sri Lanka. Data were collected as part of a national study on DM. In new cases DPN was assessed using the Diabetic-Neuropathy-Symptom (DNS) score, while in those with established diabetes both DNS and Toronto-Clinical-Scoring-System (TCSS) were used. A binary logistic-regression analysis was performed with ‘presence of DPN’ as the dichomatous dependent variable and other independent co-variants. The study included 528 diabetic patients (191-new cases), with a mean age of 55.0 ± 12.4 years and 37.3% were males, while 18% were from urban areas. Prevalence of DPN according to DNS score among all patients, patients with already established diabetes and newly diagnosed patients were 48.1%, 59.1% and 28.8% respectively. Prevalence of DPN in those with established DM as assessed by TCSS was 24% and the majority had mild DPN (16.6%). The remainder of the abstract is based on subjects with established DM. The prevalence of DPN in males and female was 20.0% and 26.4% respectively. The mean age of those with and without DPN was 62.1 ± 10.8 and 55.1 ± 10.8 years respectively (p < 0.001). The majority of those with DPN were from rural-areas (75.3%) and earned a monthly income < Sri Lankan Rupees 12,000 (87.6%). In the binary logistic-regression presence of foot ulcers (OR:10.4; 95%CI 1.8–16.7), female gender (OR:6.7; 95%CI 2.0–9.8) and smoking (OR:5.9; 95%CI 1.4–9.7) were the strongest predictors followed by insulin treatment (OR:4.3; 95%CI 1.3–6.9), diabetic retinopathy (OR:2.7; 95%CI 1.3–5.4), treatment with sulphonylureas (OR:1.8; 95%CI 1.1–3.2), increasing height (OR:1.8; 95%CI 1.2–2.4), rural residence (OR:1.8; 95%CI 1.1–2.5), higher levels of triglycerides (OR:1.6; 95%CI 1.2–2.0) and longer duration of DM (OR:1.2; 95%CI 1.1–1.3). There is a high prevalence of DPN among Sri Lankan adults with diabetes. The study defines the impact of previously known risk factors for development of DPN and identifies several new potential risk factors in an ethnically different large subpopulation with DM.Keywords
This publication has 37 references indexed in Scilit:
- Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients: a randomized multicentre survey in 12 city hospitals of ChinaDiabetes/Metabolism Research and Reviews, 2010
- Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in BangladeshInternational Journal of Diabetes in Developing Countries, 2010
- Diabetic nephropathyDiabetology & Metabolic Syndrome, 2009
- Elevated Triglycerides Correlate With Progression of Diabetic NeuropathyDiabetes, 2009
- Diabetic complications and glycaemic control in remote North AfricaQJM: An International Journal of Medicine, 2008
- Prevalence and projections of diabetes and pre‐diabetes in adults in Sri Lanka—Sri Lanka Diabetes, Cardiovascular Study (SLDCS)Diabetic Medicine, 2008
- Prevalence of Peripheral Neuropathy In Newly Diagnosed Type 2 Diabetics MellitusInternational Journal of Diabetes in Developing Countries, 2005
- Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetesDiabetic Medicine, 2004
- The Aetiology of Diabetic Neuropathy: the Combined Roles of Metabolic and Vascular DefectsDiabetic Medicine, 1995
- The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans.BMJ, 1985